These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 18404247

  • 1. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.
    Narita I, Gejyo F.
    Clin Exp Nephrol; 2008 Oct; 12(5):332-338. PubMed ID: 18404247
    [Abstract] [Full Text] [Related]

  • 2. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 3. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
    Leung JC, Poon PY, Lai KN.
    J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
    [Abstract] [Full Text] [Related]

  • 4. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Feb; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 5. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007 Feb; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L, Wang L, Huang J, Fan J.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):227-30. PubMed ID: 20337060
    [Abstract] [Full Text] [Related]

  • 8. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, Novak J, Vrtovsnik F, Haddad E, Chintalacharuvu KR, Monteiro RC.
    J Am Soc Nephrol; 2004 Mar; 15(3):622-34. PubMed ID: 14978164
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of IgA nephropathy.
    Barratt J, Feehally J, Smith AC.
    Semin Nephrol; 2004 May; 24(3):197-217. PubMed ID: 15156526
    [Abstract] [Full Text] [Related]

  • 10. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
    Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.
    Biochemistry; 2010 Jul 13; 49(27):5671-82. PubMed ID: 20507092
    [Abstract] [Full Text] [Related]

  • 11. IgA nephropathy and aberrant glycosylation of tonsillar, serum and glomerular IgA1.
    Hiki Y, Ito A, Yamamoto Y, Yamamoto K, Iwase H.
    Adv Otorhinolaryngol; 2011 Jul 13; 72():68-70. PubMed ID: 21865693
    [Abstract] [Full Text] [Related]

  • 12. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr 13; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 13. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
    Leung JC, Tang SC, Chan DT, Lui SL, Lai KN.
    J Clin Lab Anal; 2002 Apr 13; 16(1):11-9. PubMed ID: 11835525
    [Abstract] [Full Text] [Related]

  • 14. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.
    Kidney Int; 2001 Mar 13; 59(3):1077-85. PubMed ID: 11231363
    [Abstract] [Full Text] [Related]

  • 15. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct 13; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

  • 16. O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.
    Novak J, King RG, Yother J, Renfrow MB, Green TJ.
    Glycobiology; 2024 Sep 30; 34(11):. PubMed ID: 39095059
    [Abstract] [Full Text] [Related]

  • 17. Activation of the interleukin-4/signal transducer and activator of transcription 6 signaling pathway and homeodomain-interacting protein kinase 2 production by tonsillar mononuclear cells in IgA nephropathy.
    He L, Peng Y, Liu H, Yin W, Chen X, Peng X, Shao J, Liu Y, Liu F.
    Am J Nephrol; 2013 Sep 30; 38(4):321-32. PubMed ID: 24107646
    [Abstract] [Full Text] [Related]

  • 18. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy.
    Allen AC, Harper SJ, Feehally J.
    Clin Exp Immunol; 1995 Jun 30; 100(3):470-4. PubMed ID: 7774058
    [Abstract] [Full Text] [Related]

  • 19. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.
    Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J.
    Kidney Blood Press Res; 2008 Jun 30; 31(1):29-37. PubMed ID: 18182777
    [Abstract] [Full Text] [Related]

  • 20. Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy.
    Nihei Y, Suzuki H, Suzuki Y.
    Front Immunol; 2023 Jun 30; 14():1165394. PubMed ID: 37114051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.